Flourish Research

Atherosclerotic Cardiovascular Disease (ASCVD) Self-Scheduler

To qualify for this research study, participants must: 

  • Be 45 years old or older 
  • Be overweight and have established Atherosclerotic Cardiovascular Disease (ASCVD) and/or Chronic Kidney Disease (CKD) 
  • Have a BMI greater than or equal to 27.0 kg/m2 (Click to calculate) 
  • Be willing to use a highly effective form of birth control  
  • Not have Type 1 Diabetes or a history of diabetic ketoacidosis  
  • Not have had one or more episode of severe hypoglycemia in the past 90 days 
  • Not have had any of the following in the past 90 days: 
    • Heart attack, acute coronary syndrome, stroke,coronary, peripheral, or carotid artery arterial revascularization procedure, or heart failure 
  • Not have received any form of dialysis in the past 90 days 
  • Not have undergone a kidney transplant or have a transplant procedure scheduled 
  • Not have had or plan to have a surgical treatment for obesity 
  • Not have a history of chronic or acute pancreatitis 
  • Not have a family or personal history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 
  • Not have acute or chronic hepatitis, or any signs or symptoms of any other liver disease 
  • Not have a history of cancer in the past 5 years (except skin, cervical, or prostate cancer) 
  • Not have a history of an organ transplant or expecting to have an organ transplant 
  • Not have participated in a clinical study involving an investigational study intervention within the last month 
  • Additional criteria will apply  

PLEASE NOTE: Please confirm your eligibility before your appointment by calling +1 305-631-6704

If you do not see an available appointment, please call +1 305-631-6704 for availability. 

Transportation may be available. Call +1 305-631-6704. Compensation may be available for time and travel 


Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.

Exciting News! ENCORE™ is now part of the Flourish family!